[Evolution of the specific radioactivity of noradrenaline- 3 H in different organs of the rat in vivo after tyrosine hydroxylase inhibition].
D000818:Animals; D006321:Heart / Q000187:drug effects; D007421:Intestine, Small / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009132:Muscles / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D009928:Organ Specificity; D051381:Rats; D011919:Rats, Inbred Strains; D013363:Submandibular Gland / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism
D008781:Methyltyrosines; D014316:Tritium; D006899:Mixed Function Oxygenases; D014446:Tyrosine 3-Monooxygenase; D009638:Norepinephrine
Evolution de la radioactivité spécifique de la noradrénaline- 3 H dans différents organes du rat in vivo après inhibition de la tyrosine hydroxylase.